The effects of a live attenuated influenza vaccine and subsequent challenge with virulent influenza virus on the delayed hypersensitivity skin test, and the in vitro response of lymphocytes were evaluated. Volunteers were skin tested before and after administration of vaccine or placebo and challenge with PPD (a purified protein derivative of Mycobacterium tuberculosis), candida, mumps, and trichophytin, and their lymphocytes were tested for [3H Jthymidine uptake in response to phytohemagglutin. Of eight volunteers who showed evidence of viral replication after administration of the attenuated vaccine, four had a significant diminution in their skin test response, whereas 8 of 13 volunteers infected with virulent influenza virus showed a diminution. Of the 21 volunteers who were infected with either attenuated or virulent influenza virus, 12 showed suppression of their phytohemagglutin response. None of the volunteers who were given placebo vaccine, or who showed no evidence for viral replication after immunization or challenge, had a suppression of their skin test or phytohemagglutin responses. Although most of the infected volunteers demonstrated suppression of their T-cell function, there was no evidence of a similar suppression of B-cell function.
The immunosuppression found in various clinical states is associated with an increased incidence of malignancies (13, 19) . The possibility that viruses could suppress their host's immune system was first raised by von Pirquet in 1908 (24) ; if common viral infections are shown to induce an immunosuppressed state for a significant period of time, an important factor in carcinogenesis might be elucidated. This is especially significant with respect to respiratory viral infections like influenza, rhinovirus, etc., since they are the most common infectious diseases of humans.
In 1919 Bloomfield and Mateer (5) reported 19 consecutive cases of acute influenza in which only one patient had a positive tuberculin reaction, whereas 17 patients had positive reactions 1 to 11 days after the febrile stage subsided. Their observations have recently been confirmed by Reed et al. (27) who found suppression of cutaneous reactions to a purified protein derivative of Mycobacterium tuberulosis (PPD), candida, trichophytin, and coccidioidin in seven cases of influenza serologically confirmed. Immunization of normal individuals with killed influenza vaccine had no effect on cutaneous reactivity. Four patients' lymphocytes were studied in vitro at the time of cutaneous anergy and had normal responses to stimulation with phytohemagglutin (PHA). However, another study found significant suppression of PHA stimulation in all its 15 patients with acute influenza (26) .
This study was undertaken in volunteers to evaluate the effects of live attenuated influenza vaccine and subsequent challenge with virulent influenza virus (i) on cutaneous reactivity to PPD, candida, mumps, and trichophytin, and (ii) on the in vitro response of lymphocytes. (18) , for serum (8) and nasal secretion antibody rise by the virus neutralization test (32) , and for clinical evidence of respiratory infection (11) .
Immunological evaluation. Two days prior to virus challenge, blood was drawn for lymphocyte studies, and baseline skin tests to candida, mumps, PPD, and trichophytin were performed. These were repeated 3 days after challenge and once again two weeks after challenge.
(i) Intradermal skin tests were read 48 h after installation and recorded as millimeters of induration.
(ii) PHA stimulation. Peripheral leukocytes were separated from the plasma of heparinized blood samples, centrifuged, and washed once in Hanks balanced salt solution. The cells were resuspended in Eagle medium (containing 20% fetal bovine serum, 100 ,g of streptomycin, 100 U of penicillin per milliliter, and 0.3 g of bicarbonate per 100 ml) and adjusted to a final concentration of 10" leukocytes per ml. Cultures were prepared in quadruplicate with 2 ml of cell suspension per culture. Phytohemagglutinin-M (Difco; 0.05 ml) was added to each culture as a mitogen, and the cultures were incubated in 5% CO2
at 37 C for 72 h. Deoxyribonucleic acid synthesis was measured by the incorporation of [3H ]thymidine into acid-soluble material.
[3H]Thymidine (1 uCi) (specific activity of 1.9 Ci/mmol, 1 uCi per 2 uliters, Schwarz BioResearch) was added to the cultures for the last 24 h of incubation. The cultures were then centrifuged, and the cell pellets were washed twice with cold saline and twice with trichloracetic acid at 4 C. The resulting precipitates were then washed once with methanol, air dried, and solubilized (Nuclear Chicago Solubilizer, 0.25 ml per culture). Fifteen milliliters of scintillation fluid (5 g of 2,5-diphenyloxazole-1-benzene per ml in toluene) was added to the solubilized precipitates, and the solutions were transferred to scintillation vials. The vials were counted in a liquid scintillation counter (Beckman, model LS 250). The technique gave counts consistently within 5 to 10% for replicate cultures. The ratio of uptake of thymidine by the stimulated culture to the uptake of a simultaneously incubated unstimulated culture was calculated as the stimulation ratio. The ratio of the uptake of the unstimulated culture of volunteer's lymphocytes to that of control's unstimulated lymphocytes was calculated as the background ratio.
(iii) Antibody to rubella virus was measured by the hemagglutination-inhibition technique previously described (25) .
RESULTS
Of the 27 volunteers, 13 received the attenuated vaccine and 8 showed virus replication, as evidenced by a serum or secretory antibody rise (Table 1) . A significant reduction in skin test reactivity was scored if all the preinoculation-positive skin tests showed a 50% or greater reduction in the diameter when tested 72 to 96 h after inoculation. Four volunteers were observed to have such a reduction after the first dose of vaccine or placebo (Table 2) ; all were in the vaccine group and all evidenced viral replication (one had virus isolated from a throat gargle, and all showed a significant antibody rise).
PHA was used as a nonspecific stimulus of blastogenesis of the subjects' peripheral lymphocytes. This was measured by [3H Ithymidine uptake and was considered abnormal if the stimulation ratio was < 10 or if the background ratio was > 2.5. After the first dose of vaccine or placebo, seven volunteers developed a transient abnormality of their PHA response, and all were in the vaccine group and all evidenced viral replication (Table 3) . Thus, of the eight vaccinees who showed virus replication, all but one developed an abnormal PHA response.
Following the second dose of vaccine or placebo, two volunteers showed virus replication, as evidenced by a fourfold or greater antibody rise. None had a significant reduction in skin test reactivity or an abnormality of their PHA response.
Four to eight weeks after the second dose of vaccine or placebo, the volunteers were challenged with virulent influenza virus. Thirteen of the 27 showed virus replication, as evidenced by a significant antibody rise, and in addition, seven had clinical influenza and four had virus isolated from a throat gargle (Table 1) . Eight volunteers were observed to have a significant reduction in their delayed hypersensitivity skin test response, and all had a fourfold or greater rise in serum and/or secretory influenza virus neutralizing antibody (Table 2) . Five developed a transient abnormality of their PHA response, and also, they were all infected (Table 3) . Of the 13 volunteers who showed an antibody response, 12 developed an abnormality of one of the two parameters of cell-mediated immunity that were measured.
In the volunteers who had a significant reduction in skin test reactivity, the mean diameter changed from 18 to 3 mm. Seven of the 12 showed a complete disappearance of skin test reactivity. In all but one case, the skin test reactivity had returned by the time the volunteers were retested 2 weeks later. In that one individual, the skin test reactivity returned to normal at some point between 2 and 4 weeks after the infection.
The PHA abnormality was of longer duration than the skin test depression in two cases lasting from 2 to 4 weeks. The usual abnormality noted in the PHA response was a decreased stimulation ratio. The one exception was a case in which there was an increased background VOL. 10, 1974 997 Thus, the incidence of immunosuppression was not significantly different in those who were infected with the attentiated as compared to the virulent influenza virus.
To assess B-cell function, antibody to rubella virus, an unrelated antigen, was measured before, during, and after influenza virus infection.
In no instance was there a significant (fourfold or greater) change in titer during the period of observation. DISCUSSION Von Pirquet observed that children lost their skin reactivity to tuberculin a few days prior to the exanthem of measles, gradually becoming positive 5 to 10 days after the rash subsided (24) . He also noted that tuberculosis tended to become active after measles. Suppression of the tuberculin test during measles has subsequently been confirmed (3, 14, 21) . More recently, live attenuated measles vaccine has been shown to suppress the tuberculin reaction (6, 20, 30) , whereas killed vaccine had no effect (10) . Live Good (13) .
There is a tenfold increase in the incidence of malignancies arising de novo in patients under immunosuppressive regimen for organ transplantation (12, 19, 31 
